摘要 |
<p>The subject invention provides means of identifying agents identified as capable of reducing levels of ROS or ROS level correlated indicators such as levels of LPs, AGEs, NFkB, PKC, or aldose reductase activation in insulin-independent cells grown under high glucose conditions.</p> |